Cha Biotech cuts vaccine stake, bets on CGT, AI

Cha Biotech said Thursday it will transfer 8.95 million shares in Cha Vaccine Institute, worth 23.8 billion won ($15.8 million), to Solux, AriBio Investment Purpose No. 13 and other investors. Following the deal, Cha Biotech’s stake in the Kosdaq-listed affiliate will fall to 1.34 million shares, or 4.99 percent, marking a strategic exit from management control while retaining a minority stake for future collaboration. The proceeds will be used to strengthen core growth areas, including cell and

By The Korea Herald